Page 18 - Shimadzu Journal vol.9 Issue2
P. 18

Biopharmaceutical



                          Liquid Chromatograph Mass Spectrometer LCMS™-9030


               Characterization of Control and Stress


          Induced Samples of Trastuzumab Biosimilar




                               Amita Puranik , Ratnesh Jain , Deepti Bhandarkar , Pratap Rasam , Prajakta Dandekar , Tian hua Wang 4
                                                           2
                                                1
                                        1
                                                                                3
                                                                    2
                               1 Department of Chemical Engineering, Institute of Chemical Technology, Mumbai
                               2 Shimadzu Analytical (India) Pvt. Ltd.
                               3 Department of Pharmaceutical Science and Technology, Institute of Chemical Technology, Mumbai
                               4 Shimadzu (Asia Pacific) Pte. Ltd.
             User Benefits
                                                               deamidation are the most commonly observed Post-Translational
            ・  In-depth peptide mapping and PTM analysis methodology is described
              for the analysis of control and stress induced samples of mAb which   Modifications (PTMs). Early identification of these prone sites en-
              can  be  useful  in  identification  of  sites  susceptible  to  oxidation  and   ables antibody engineering to eliminate liability of leading candi-
              deamidation modifications
                                                               dates to such modifications while maintaining binding activity.
            ・  Excellent  and  stable  mass  accuracy,  comprehensive  fragmentation
              pattern  and  high  sensitivity  offered  by  LCMS-9030  helped  obtain   Bottom-up approach which is essentially peptide mapping helps
              good sequence coverage, identification of PTMs and sites susceptible     in determination of primary amino acid sequence and identifica-
              for modifications
                                                               tion of site–specific PTMs. In this application note, methodology
                                                               for identification of sites susceptible to oxidation and deamidation
                                                               is described by analyzing the control and artificial chemically stress
                            Introduction                       induced (forced degradation) samples of mAb.


            Monoclonal antibodies (mAbs) are a major class of biopharmaceu-
            ticals covering a large panel of diseases, from cancer to asthma,   Experimental
            including  central  nervous  system  disorders,  infectious  diseases
            and cardiovascular diseases . Throughout manufacturing, storage,   Trastuzumab biosimilar sample (2 mg/mL) was incubated in water
                               1
            transportation, and administration, mAbs are subjected to biophys-  with pH 9 (adjusted using tris base solution) for 7 days at 37°C to
            ical and biochemical stress from multiple sources, which may lead   induce deamidation. Similarly, 10 µL of 30% H O  solution was
                                                                                                 2  2
            to their degradation via aggregation, fragmentation, and chemical   added to 2 mg/mL of trastuzumab sample and incubated for 1 hour
                                                         2
            modifications, such as oxidation, deamidation, or isomerization .   at 37°C to induce oxidation. Oxidation reaction was quenched by
            Among these undesirable degradation products, oxidation and   adding pinch of methionine.




                                                                                                Shimadzu Journal  vol.9  Issue2 51
   13   14   15   16   17   18   19   20   21   22   23